Targeted Temperature Management Via Bladder Monitoring in ICH
Key facts
- Who runs it
- Yanyan Gong
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 318 people, planned
- Started
- 15 Mar 2026
- Expected to end
- 30 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Bladder Temperature Monitoring
- Standard Temperature Monitoring Group
- Record updated
- 10 June 2026
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Neurocritical care patients: Study subjects are patients with first-time spontaneous intracerebral hemorrhage
- Age ≥ 18 years and ≤ 85 years
- Glasgow Coma Scale (GCS) score ≤ 8 at ICU admission
- For supratentorial ICH: Hematoma volume < 60 mL. For subarachnoid hemorrhage (SAH): Modified Fisher grade ≥ 2, and the aneurysm has been treated with endovascular intervention
- Pre-morbid modified Rankin Scale (mRS) score of 0 or 1
- Signed informed consent provided by a legally authorized representative
Who cannot take part
- Fever (≥38.0°C) that lasted over 1 hour or occurred more than once prior to enrollment
- Underlying conditions with a life expectancy of less than 6 months, estimated prior to onset
- Severe injury indicative of poor prognosis: brain death, receiving palliative care only, or irreversible brain injury
- Currently participating in other investigational/interventional clinical trials (involving medical devices or drugs)
- Pre-existing neurological, psychiatric, or other comorbidities that may compromise the assessment of neurological or functional outcomes
- Pregnancy
- Unilateral or bilateral pupillary dilation
- Subjects deemed ineligible for enrollment by the investigator
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn whether a bladder temperature monitoring-guided targeted temperature management (TTM) strategy improves functional recovery in patients with severe intracerebral hemorrhage, compared to conventional temperature monitoring. It will also assess the safety of this monitoring approach. The main questions it aims to answer are:
Read full original descriptionShow less
* Does continuous bladder temperature monitoring-guided TTM improve the likelihood of a favorable functional outcome (modified Rankin Scale score 0-2) at 180 days after onset? * What medical problems (such as infections, shivering, deep vein thrombosis, or sepsis) do participants experience while under the TTM strategy? Researchers will compare the intervention group (using continuous bladder temperature monitoring) with the control group (using conventional intermittent temperature monitoring with a mercury thermometer at the armpit) to see if the bladder temperature-guided TTM strategy leads to better outcomes.
Participants will:
* Be randomly assigned to one of the two temperature monitoring strategies * Receive standard medical and surgical care for severe intracerebral hemorrhage
The 2 groups in the trial
- Bladder Temperature Monitoring GroupTreatment being tested
Patients in this arm will receive Targeted Temperature Management (TTM) guided by continuous, real-time core temperature monitoring via a bladder thermometer. TTM may include therapeutic hypothermia (TH, 32.0°C ≤ temp \< 36.0°C), normothermia control (36.0-37.5°C), or fever treatment, as clinically indicated. Temperature is recorded hourly.
Treatment: Bladder Temperature Monitoring
- Standard Temperature Monitoring GroupExisting treatment, for comparison
Patients in the control arm will receive Targeted Temperature Management (TTM) guided by intermittent axillary temperature measurements using a mercury-in-glass thermometer, recorded every four hours. TTM may include therapeutic hypothermia, maintenance of normothermia, or treatment of fever, as clinically indicated.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Safety and Efficacy of Bladder Temperature Monitoring-Guided Targeted Temperature Management in Patients With Severe : A Multicenter Randomized Controlled Trial
- Criteria questions
- Built from NCT07302009, who can take part
- Record updated
- 10 June 2026